SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001650664-24-000121
Filing Date
2024-11-04
Accepted
2024-11-04 07:36:46
Documents
57
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q edit-20240930.htm   iXBRL 10-Q 884806
2 EX-31.1 edit-20240930xex311.htm EX-31.1 9648
3 EX-31.2 edit-20240930xex312.htm EX-31.2 9621
4 EX-32.1 edit-20240930xex321.htm EX-32.1 6478
  Complete submission text file 0001650664-24-000121.txt   4551010

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT edit-20240930.xsd EX-101.SCH 27118
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT edit-20240930_cal.xml EX-101.CAL 50054
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT edit-20240930_def.xml EX-101.DEF 122777
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT edit-20240930_lab.xml EX-101.LAB 484110
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT edit-20240930_pre.xml EX-101.PRE 302157
59 EXTRACTED XBRL INSTANCE DOCUMENT edit-20240930_htm.xml XML 540608
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37687 | Film No.: 241420768
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)